semaglutide eye disease A new study suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an condition that can cause blindness. Non-arteritic anterior Should You Be Worried About

The efficacy and safety of SGLT2 inhibitor in diabetic kidney transplant recipients

I definitely recommend

You are not a good a candidate for GLP 1based weight management if you: Are currently diagnosed with Type 1 diabetes and dependent on insulin Are pregnant, planning pregnancy or breastfeeding Have medical conditions that would prevent safe use of these medications A provider will review your health history to determine whether this program is appropriate for you

Health Canada approved the launch on April 28, 2026

This dual mechanism can reignite weight loss in patients whose bodies have adapted to single-pathway stimulation

By reducing appetite and increasing feelings of fullness, GLP-1 medication enables individuals to better control their food intake and achieve sustainable weight management